Skip to main content
Log in

Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

A controlled cross-over clinical comparison of lactose (50 g twice a day) versus neomycin (3 g/day) plus milk of magnesia, was carried out in ten cirrhotic patients with chronic portal-systemic encephalopathy and documented lactase deficiency. Serial semiquantitative assessments were done including: mental state, asterixis, number connection test, electroencephalogram, and blood ammonia levels. No patient developed deep coma while ingesting either lactose or neomycin plus milk of magnesia. However, a significant improvement of mental state, asterixis, number connection tests, and electroencephalograms was evident during lactose therapy. Apart from mild diarrhea and bloating, no severe side effects were noticeable during lactose treatment. Based on these results, we propose lactose as a valuable alternate treatment of portal-systemic encephalopathy in lactase-deficient populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seef L, Levy LL: Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double-blind controlled trial. Gastroenterology 72:573–583, 1977

    Google Scholar 

  2. Attebury CE, Maddrey WC, Conn HO: Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis 23:398–406, 1978

    Google Scholar 

  3. Welsh JD, Langdon DE. Lactose in the treatment of hepatic encephalopathy in the patient with lactose malabsorption. N Engl J Med 286:436, 1972

    Google Scholar 

  4. Welsh JD Cassidy D, Prigatano GP, Gunn CG: Chronic hepatic encephalopathy treated with oral lactose in a patient with lactose malabsorption. N Engl J Med 291:240–241, 1974

    Google Scholar 

  5. Lisker R, López-Habib G, Daltabut M: Lactase deficiency in a rural area of Mexico. Am J Clin Nutr 27:756–759, 1974

    Google Scholar 

  6. Lisker R, Aguilar L: Double-blind study of milk lactose intolerance. Gastroenterology 74:1283–1285, 1978

    Google Scholar 

  7. Lisker R, López-Habib G, Mora MA: Correlation in the diagnosis of intestinal lactase deficiency between the radiological method and the lactose tolerance test. Rev Invest Clin (Mex) 27:1–5, 1975

    Google Scholar 

  8. Uribe M, Farca A, Márquez MA, García-Ramos G, Guevara L: Treatment of chronic portal-systemic encephalopathy with bromocriptine. A double-blind controlled study. Gastroenterology 76:1347–1351, 1979

    Google Scholar 

  9. McDermmott WV, Adams PD, Riddell AG: Ammonia levels in blood and cerebrospinal fluid. Proc Soc Exp Biol 88:380–383, 1955

    Google Scholar 

  10. Márquez MA, Murillo H, García-Ramos G, Guevara L, Uribe M: Control de la encefalopatía hepática crónica con dieta de proteínas vegetales. Rev Gastroenterol Mex 43:214, 1978 (abstract)

    Google Scholar 

  11. Rickmers A, Todd HN: Introducción a la estadística, 2nd ed. Barcelona, Spain, Editado por Compañía Editorial Continental, S.A., 1974, pp 90–93

    Google Scholar 

  12. Berk DP, Chalmers T: Deafness complicating antibiotic therapy of hepatic encephalopathy. Ann Intern Med 73:393–396, 1970

    Google Scholar 

  13. Greenberg LH, Momary H: Audiotoxicity and nephrotoxicity due to orally administered neomycin. J Am Med Assoc 194:237–243, 1965

    Google Scholar 

  14. Jacobsen EP, Prior JT, Faloon WW: Malabsorptive syndrome induced by neomycin: Morphologic alterations in the jejunal mucosa. J Lab Clin Med 56:245–250, 1960

    Google Scholar 

  15. Kaupe C, Sprague T, Gitnick GL: Hyponatremia after the administration of lactulose. Ann Intern Med 86:745, 1977

    Google Scholar 

  16. Hoyumpa AM, Desmond PV, Avant GR, Schenker S: Hepatic encephalopathy. Gastroenterology 76:184–195, 1979

    Google Scholar 

  17. Rojas S, Moreno J, Galván E, Uribe M: Efecto de la lactosa lactulosa y neomicina sobre la generación de amonio y la flora bacteriana. Rev Gastroenterol Mex 44:226, 1979 (abstract)

    Google Scholar 

  18. Sowers MF, Winterfeld E: Lactose intolerance among Mexican Americans. Am J Clin Nutr 28:704–705, 1975

    Google Scholar 

  19. Bayless TM, Rosenweig NS: A racial difference in incidence of lactose deficiency: A survey of milk intolerance and lactase deficiency in healthy adult males. J Am Med Assoc 197:968–972, 1966

    Google Scholar 

  20. Newcomer AD, Thomas PJ, McGill DB, et al Lactase deficiency: A common genetic trait of the American Indians. Gastroenterology 72:234–237, 1977

    Google Scholar 

  21. Bolin TD, Davis AE: Asian lactose intolerance and its relation to intake of lactose. Nature 222:383, 1969

    Google Scholar 

  22. Chung MH, McGill BD: Lactase deficiency in Orientals. Gastroenterology 54:225–226, 1968

    Google Scholar 

  23. Gilat TR, Kuhn E, Gelman E, et al: Lactase deficiency in Jewish communities in Isreal. Am J Dig Dis 15:895–904, 1970

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

With technical assistance of Arabella Briones, BS, and Sofía Gil, BS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uribe, M., Márquez, M.A., García-Ramos, G. et al. Treatment of chronic portal-systemic encephalopathy with lactose in lactase-deficient patients. Digest Dis Sci 25, 924–928 (1980). https://doi.org/10.1007/BF01308043

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01308043

Keywords

Navigation